ARAP3 and Alzheimer disease: While the phosphoinositide metabolism is dysregulated in AD19,21, it is not clear yet whether this altered phosphoinositide metabolism also affects the function of ARAP3 and contributes to the neurotoxicity in Aβ-induced AD model.